Leiden University Scholarly Publications

Search results

(73 - 96 of 253)

Pages

: Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry

: Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR Register

: SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patients

: What is the optimal target for treat-to-target strategies in rheumatoid arthritis?

: Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes

: Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis

: Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study

: What have we learned from BeSt?

: Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?

: Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis

: Repair of Joint Damage Is Rare in Newly Diagnosed Rheumatoid Arthritis Patients and Appears Not to Relate to Previous Suppression of Inflammation

: Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy

: Do We Treat Men and Women Differently, and Is This a Good Thing?

: The Presence of a Large Number of Autoantibodies at Baseline Is Favourable for Early Treatment Response but Unfavourable for Drug-Free Remission in RA Patients

: Meta-Regression of a Dose-Response Relationship of Methotrexate in Mono- and Combination Therapy in Disease-Modifying Antirheumatic Drug-Naive Early Rheumatoid Arthritis Patients

: Three Treatment Strategies in Recent Onset DMARD Naive Juvenile Idiopathic Arthritis: First Results of Clinical Outcome after 24 Months

: In RA, Becoming Seronegative over the 1st Year of DMARD Treatment Does Not Improve Chances of Drug-Free Remission in the Long-Term

: Further Treatment Intensification in Undifferentiated and Rheumatoid Arthritis Patients Already in Low Disease Activity has Limited Benefit towards Physical Functioning

: Pathway analysis to identify genetic variants associated with efficacy of adalimumab in rheumatoid arthritis

: Time-averaged disease activity fits better joint destruction in rheumatoid arthritis

: PROLONGED TNF-INHIBITOR TREATMENT DURATION IS ASSOCIATED WITH LOWER RISK OF HAND OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH RECENT-ONSET RHEUMATOID ARTHRITIS AFTER 10-YEAR FOLLOW-UP

: SIMILAR SHORT TERM CLINICAL RESPONSE TO INITIAL TREATMENT WITH HIGH VERSUS LOW DOSE METHOTREXATE IN MONO- AND COMBINATION THERAPY IN EARLY RHEUMATOID ARTHRITIS PATIENTS

: Disturbance of Microbial Core Species in New-Onset Juvenile Idiopathic Arthritis

: RHEUMATOID ARTHRITIS PATIENTS WITH CONTINUED LOW DISEASE ACTIVITY HAVE SIMILAR OUTCOMES OVER 10 YEARS, REGARDLESS OF INITIAL THERAPY

Pages